HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 201 filers reported holding HERBALIFE LTD in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $29,000 | -39.6% | 996 | -2.9% | 0.00% | – |
| Q4 2019 | $48,000 | +23.1% | 1,026 | -0.1% | 0.00% | – |
| Q3 2019 | $39,000 | -11.4% | 1,027 | -1.0% | 0.00% | – |
| Q2 2019 | $44,000 | -20.0% | 1,037 | -0.4% | 0.00% | – |
| Q1 2019 | $55,000 | -11.3% | 1,041 | -0.6% | 0.00% | – |
| Q4 2018 | $62,000 | +10.7% | 1,047 | +1.4% | 0.00% | – |
| Q3 2018 | $56,000 | 0.0% | 1,033 | -0.4% | 0.00% | – |
| Q2 2018 | $56,000 | +9.8% | 1,037 | +99.0% | 0.00% | – |
| Q1 2018 | $51,000 | +45.7% | 521 | 0.0% | 0.00% | – |
| Q4 2017 | $35,000 | -35.2% | 521 | -47.9% | 0.00% | – |
| Q4 2015 | $54,000 | -1.8% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $55,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $55,000 | +27.9% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $43,000 | +13.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $38,000 | -13.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $44,000 | -32.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $65,000 | -62.2% | 1,000 | -66.7% | 0.00% | – |
| Q1 2014 | $172,000 | -27.1% | 3,000 | 0.0% | 0.00% | – |
| Q4 2013 | $236,000 | +12.9% | 3,000 | 0.0% | 0.00% | – |
| Q3 2013 | $209,000 | +53.7% | 3,000 | 0.0% | 0.00% | – |
| Q2 2013 | $136,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |